Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale

In 2024, medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale trade exhibited modest growth, with global flows reaching $4,879,368,058 and a three-year compound annual growth rate of +1.7% (five-year: -0.6%). The all-time peak of $5,609,477,544 was recorded in 2015; the current level is 13% below that high-water mark.

Over the 30-year observation window (1995–2024), 62% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (+1.3% acceleration).

The supply side is diversified (Herfindahl-Hirschman Index 0.105). The three largest exporters — Germany ($1.3B), India ($425.5M), and France ($424.1M) — collectively dominate supply flows. The leading exporter has grown at -7.8% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.110). The three largest import markets are United States ($1.5B), China ($274.3M), and France ($262.3M). The largest importing market sources from 45 different supplying countries.

The dominant trade corridor is Germany → United States at $552.3M, representing 36.8% of the importer's total demand.

The volatility score for medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale is 4 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, modest but steady demand provides a reasonable entry window. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.